by Anna Army | Nov 19, 2020 | Blog
LaVoieHealthScience President and CEO, Donna LaVoie, contributed to the O’Dwyer’s PR News Magazine October issue focused on healthcare and medical public relations. Donna discusses what makes strategic communications and investor relations in biotech different from...
by Anna Army | Oct 30, 2020 | Blog
With ESG investing moving from tipping point to turning point, what impact will the new DOL rules have on investors and plan sponsors? Given the macro-level upheavals that have taken place so far in 2020 – from the global pandemic to the movement for racial and...
by Anna Army | Oct 14, 2020 | Blog
As announced last month, the 39th Annual J.P. Morgan Healthcare Conference will be held virtually from January 11-14, 2021 – a first for the conference. The bank’s decision to move to a fully virtual format has created a ripple effect among other shoulder...
by Anna Army | Sep 3, 2020 | Blog
The SARS-CoV-2 pathogen has scrambled literally everything around the world, including financial markets and the world economy. At the same time, the biotech and pharmaceutical industries are in the spotlight as never before as nations and companies push...
by Anna Army | Jul 1, 2020 | Blog
And is your company prepared for what may be coming next? As biotech and pharmaceutical companies work to stabilize their clinical programs and business strategies during the significant disruptions caused by the COVID-19 pandemic, one of the potential challenges that...
by Anna Army | Jun 4, 2020 | Blog
As a communications agency serving the biotech, pharmaceutical, and affiliated health science industry for over 20 years, LaVoieHealthScience has developed specific guidance for clients on how to develop and deliver highly effective corporate presentations. As a...
Recent Comments